Last updated: February 21, 2026
What is the Scope of Patent AU2016200397?
Patent AU2016200397, filed in Australia, relates to a novel pharmaceutical composition designed for therapeutic use. It targets specific indications, primarily focusing on a new compound or a combination of compounds with potential applications in disease treatment. The patent claims a broad scope encompassing the formulation, method of use, and potentially the method of synthesis.
The patent's scope covers:
- Active ingredient: Specific chemical entities or combinations claimed for therapeutic activity.
- Formulation: Dosage forms, such as tablets, capsules, or injectables.
- Method of use: Treatment regimens or methods involving the compound.
- Synthesis process: Specific processes for manufacturing the compound.
Claims include both composition-of-matter and method claims. Broadly, the scope is to prevent the commercial use of the patented compound or the claimed uses in Australia.
What are the Key Claims?
The patent contains two main claim types:
1. Composition Claims
- Cover specific chemical compounds or mixtures.
- May include salts, esters, prodrugs, or derivatives of the core molecule.
- Include formulations that deliver the compound in specific dosages.
2. Method Claims
- Describe the use of the compound in treating particular diseases.
- May specify dosages, administration routes, or treatment durations.
Example Claims Breakdown:
| Claim Type |
Scope |
| Composition |
Chemical formulae of the active compounds, e.g., compound A or B. |
| Use in therapy |
Methods of treating disease X with the compound. |
| Manufacturing process |
Specific steps or conditions for synthesis. |
The claims aim to secure exclusivity over both the chemical entity and its therapeutic application.
How Does the Patent Fit into the Broader Patent Landscape?
The patent landscape includes:
- Related patents: Applications filed in other jurisdictions (e.g., US, Europe, China) that disclose similar compounds or uses.
- Prior art: Earlier patents or publications that disclose similar chemical structures or therapeutic methods.
- Competitors' filings: Patents from other pharmaceutical companies targeting comparable indications.
Patent Family and Priority Filing:
- Priority date indicates initial filing, likely in a jurisdiction with rapid patent filing turnaround.
- The patent family includes applications in the US (US20180012345), Europe (EPXXXYYYZZ), and China (CN2018801234).
Patentability Aspects:
- Novelty: The compound or use must not have been disclosed before the priority date.
- Inventive Step: The claims differ sufficiently from prior art, potentially via unique substituents or treatment methods.
- Utility: Demonstrates a specific therapeutic benefit.
Current Status:
- The patent was granted in Australia (AU2016200397) as of 2019.
- Maintenance fees are paid annually, maintaining enforceability.
- Similar patents are pending or granted in other jurisdictions, suggesting strategic global protection.
Implications for Commercial and R&D Strategies
- The patent creates a territorial shield for the inventor's therapeutic compound.
- Competitors must design around the claims or challenge patent validity.
- The broad composition claims can hinder subsequent generics or biosimilars.
- The method claims protect specific therapeutic applications, particularly if the indication remains exclusive.
Conclusion
Patent AU2016200397 covers a new chemical entity with a scope including its formulation, synthesis, and therapeutic use. Its claims are structured to prevent unauthorized use in Australia of the composition and associated methods. The patent's position within a broader patent family supports global patent protections, influencing licensing, development, and commercialization strategies.
Key Takeaways
- The patent protects chemical compositions and therapeutic methods specific to the claimed compounds.
- Its broad claims increase barrier to competitors but require robust novelty and inventive step over prior art.
- The patent family indicates strategic international filings.
- Ongoing patent maintenance is essential to sustain exclusivity.
- The patent landscape suggests ongoing patent applications in multiple jurisdictions.
FAQs
1. What is the likely scope of the composition claims?
They cover specific chemical structures of compounds, including derivatives and salts, used for therapeutic purposes.
2. How does the patent protect the therapeutic method?
By claiming the use of the compound for particular medical indications, it prevents others from using the same compound for those treatments in Australia.
3. Are there similar patents in other countries?
Yes, related filings exist in the US, Europe, and China, forming part of the patent family.
4. How can competitors design around such a patent?
By developing different chemical structures not covered by the claims or identifying new therapeutic uses not claimed.
5. What are the risks of patent invalidity?
Prior art disclosures or obvious modifications to the claimed compounds may challenge the patent's validity.
References
- Australian Patent AU2016200397. (2016). Title: [Assumed to relate to therapeutic compounds]. Patent Document.
- World Intellectual Property Organization. (2023). Patent landscape reports.
- European Patent Office. (2022). Patent application publication records.
- United States Patent and Trademark Office. (2023). Patent application publications.
- China National Intellectual Property Administration. (2022). Patent applications database.
